Prognostic factors for survival with bevacizumab-based therapy in colorectal cancer patients: a systematic review and pooled analysis of 11,585 patients
Crossref DOI link: https://doi.org/10.1007/s12032-014-0456-z
Published Online: 2015-01-09
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Petrelli, Fausto
Coinu, Andrea
Cabiddu, Mary
Borgonovo, Karen
Lonati, Veronica
Ghilardi, Mara
Barni, Sandro
Text and Data Mining valid from 2015-01-09